Cutaneous Larva Migrans in Urban Area: A Case Report

Cutaneous larva migrans (CLM) is a zoonotic skin disorder caused by the infestation of animal hookworm larvae, the most common being Ancylostoma braziliense. The larvae penetrate the skin surface and subsequently migrate to the epidermis, leaving a typical manifestation of linear or serpiginous erythematous burrow-like tracks, known as creeping eruption. This report presented a case of a young man with complaints of the serpiginous erupted lesion over the upper left thigh, following a recent history of beach travel. On dermatological examination, an erythematous serpiginous lesion and papules were found, portraying the clinical presentation of CLM. The administration of albendazole 400 mg was started, and the symptoms were completely resolved. Keywords: larva migrans, skin disease, creeping eruption, nematodes, albendazole.

A case report of asymptomatic cutaneous larva migrans

<p>Cutaneous larvae migrans or creeping eruption is a serpiginous cutaneous eruption caused by the accidental penetration and migration of animal hookworm (nematode) larvae through the epidermis and subcutaneous tissue. The infection occurs most frequently in warmer climates and is associated with pruritus and burning sensation<span style="text-decoration: line-through;">s</span>. We report a case of 48 years old farmer with vesicular lesion on left ankle progressing into a serpiginous track on the skin surface without any characteristic symptoms. Treatment with oral and topical drugs led to successful resolution of lesions within 10 days.</p>

Office-made 4% Albendazole Cream is an Effective Alternative Therapy for Cutaneous Larva Migrans: A Report of Three Cases

Introduction. Cutaneous larva migrans (CLM), commonly called creeping eruption, is a parasitic skin disorder caused by the invasion of larva to the skin. This disease classically presents as serpiginous lesions. Larva frequently originates from fecal material of cats and dogs. The pruritus is usually intense and if not treated might disrupt activity, lead to secondary infection, and extend to other regions. Oral and topical antihelminthic agents are the first-line treatment with excellent clinical response. However, they are not always readily available, as is it the case in our region. We attempt to tackle this limitation by formulating an office-made albendazole cream. This report shows the clinical efficacy of our regimen in three cases of CLM.Case Report. We report three cases of CLM diagnosed through history taking and clinical presentation. All cases were treated with topical office-made albendazole as requested by the patients and due to resource limitation. The topical preparation was made by dissolving 400 mg albendazole tablet into sterile water and mixing it with Vaseline to form 4% cream. Three times daily application for seven days led to excellent clinical response.Conclusion. Our 4% office-made albendazole cream was shown to be effective in treating CLM. Thus, this simple and practical preparation may serve as an alternative treatment for CLM.